top of page
background.jpg

About Us

Xelcis Bio™ is a pioneer in oncology therapeutics that is focused on targeting therapies to tumors with the goal of increasing efficacy and reducing side effects. Our scientific approach combines innovative nanoparticle engineering, sophisticated chemistry, and deep oncology expertise to overcome the fundamental challenges of cancer therapy.

SCROLL DOWN

$30B+

Current Global Chemotherapy Market

$49B+

 Projected Market Size by 2030

505(b)(2)

Pathway for Faster FDA Approval

About the Company

Leading the Future of Targeted Cancer Therapy

Xelcis Bio is an innovative biotech company transforming cancer treatment through precision delivery.

At Xelcis Bio™, we are dedicated to transforming cancer treatment through innovative drug delivery technology. Our mission is to enhance the therapeutic potential of proven cancer treatments while reducing side effects, ultimately improving outcomes and quality of life for cancer patients worldwide. Through our groundbreaking TRIDENT™ platform, we're working to make precision medicine a reality in cancer care.

Vision & Mission

Shaping the Future of Cancer Care

interior-of-empty-science-laboratory-with-modern-e-2025-02-17-21-49-45-utc 2.webp

Our Vision

TRIDENT™ envisions a future where cancer treatment is characterized by therapeutic precision instead of acceptable toxicity. Employing our delivery platform, we believe patients will receive exactly the therapy their cancer requires, targeting the cancer and not healthy tissue.

interior-of-a-professional-chemical-lab-with-equip-2024-11-18-12-13-57-utc 1.webp

Our Mission

The TRIDENT™ platform represents more than technological advancement—it signifies a fundamental shift in our approach to cancer treatment. By resolving the delivery challenge, we unlock therapeutic potential across entire classes of drugs, creating a multiplier effect that extends well beyond any single therapeutic agent.

Values

Our Guiding Principles

Innovation

We push the boundaries of oncology research to develop groundbreaking therapeutic solutions.

Patient-Centric Approach

Every advancement we make is focused on improving the lives of patients, and effective treatments.

Scientific Excellence

We maintain the highest standards in research, development, and clinical practice.

Integrity & Transparency

We uphold ethical standards and clear communication with stakeholders.

Leadership Team

My headshot.png

R. Michael Dudley

CEO and Co-Founder, Director
Dr. Peter Liu

Qiyong Peter Liu, PhD

Co-Founder, Chief Scientist, & VP of R&D
Dustan Bonnin3.jpeg

Dustan Bonnin, MBA

Co-Founder and Director
Subrata5.jpeg

Subrata Ghosh, PhD

Director of Biology
AlanFreidman_edited_edited_edited.jpg

Alan Freidman

Co Founder and Director
Cynthia Pussinen.jpeg

Cynthia Pussinen

Independent Director

Our goal is to improve cancer treatment for all patients

Reach out to learn more about our technology, investment opportunity, our company and the future of cancer treatment.
bottom of page